CHIMIRRI, Alba
 Distribuzione geografica
Continente #
NA - Nord America 8.170
EU - Europa 6.447
AS - Asia 1.732
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 7
OC - Oceania 6
AF - Africa 4
Totale 16.375
Nazione #
US - Stati Uniti d'America 8.132
IE - Irlanda 1.814
SE - Svezia 1.540
UA - Ucraina 1.092
CN - Cina 994
DE - Germania 654
VN - Vietnam 506
FI - Finlandia 383
GB - Regno Unito 369
IT - Italia 322
IN - India 148
RU - Federazione Russa 71
AT - Austria 41
BE - Belgio 38
CA - Canada 36
CZ - Repubblica Ceca 36
SG - Singapore 36
FR - Francia 35
IR - Iran 24
PL - Polonia 9
NL - Olanda 8
A2 - ???statistics.table.value.countryCode.A2??? 6
CH - Svizzera 6
BG - Bulgaria 5
KR - Corea 5
IL - Israele 4
JP - Giappone 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
CL - Cile 3
EG - Egitto 3
ES - Italia 3
EU - Europa 3
PE - Perù 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
HU - Ungheria 2
LU - Lussemburgo 2
RO - Romania 2
TR - Turchia 2
AL - Albania 1
BR - Brasile 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
Totale 16.375
Città #
Jacksonville 2.073
Dublin 1.812
Chandler 1.403
Nyköping 1.010
Dong Ket 505
Beijing 473
Ashburn 445
Cambridge 357
Princeton 354
Dearborn 333
Medford 300
Des Moines 270
Boardman 233
Ann Arbor 150
Lancaster 130
Woodbridge 110
Wilmington 96
Jinan 72
Hyderabad 68
San Mateo 68
Nanjing 65
Pune 54
Messina 50
Shenyang 48
Vienna 41
Haikou 39
Los Angeles 38
Brussels 35
Milan 33
Brno 31
Hebei 31
Zhengzhou 30
Houston 26
Ningbo 26
Seattle 26
Catania 25
Lappeenranta 23
Saint Petersburg 22
Taizhou 21
Tianjin 21
Fuzhou 20
Hangzhou 20
New York 20
Singapore 20
Washington 20
Ardabil 19
Norwalk 19
Augusta 18
Nanchang 17
Ottawa 17
Leawood 15
Monmouth Junction 15
Taiyuan 14
Changsha 12
Jiaxing 12
Auburn Hills 11
Edinburgh 11
Guangzhou 11
London 11
Hanover 10
Clearwater 8
Montréal 8
Brooklyn 7
Hefei 7
Helsinki 7
Kunming 7
Munich 7
Phoenix 7
Warsaw 7
Chicago 6
Mcallen 6
Nicotera 6
Novokuznetsk 6
Nuremberg 6
Riva 6
Rome 6
Amsterdam 5
Bremen 5
Dallas 5
Olomouc 5
Sofia 5
Toronto 5
Auckland 4
Bangalore 4
Catanzaro 4
Florence 4
Mumbai 4
Nanning 4
Saint Louis 4
Tappahannock 4
West Jordan 4
Amelia 3
Brugherio 3
Como 3
Cormeilles-en-Parisis 3
Falls Church 3
Ferrara 3
Frankfurt am Main 3
Frigento 3
Kemerovo 3
Totale 11.459
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 192
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 151
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 144
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 141
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 141
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 140
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 139
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 131
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 89
AMPA receptor antagonists: Synthesis and pharmacological evaluation 89
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 88
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 77
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 77
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 76
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 74
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 72
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 72
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 72
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 69
Anti-HIV agents: design and discovery of new potent RT inhibitors 68
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 67
Design and synthesis of acetylcholinesterase inhibitors 66
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 66
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 65
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 65
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 65
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 65
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 64
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 64
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 63
Binding modes of noncompetitive AMPA antagonists: a computational approach 63
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 62
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 62
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 62
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 62
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 62
Annelated 1,5-benzothiazepines 62
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 61
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 61
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 61
High-performance liquid chromatographic determination of new 2,3-benzodiazepines 61
Synthesis and pharmacological evaluation of new tetrahydroisoquinoline derivatives. 61
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 61
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 61
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 61
Azirino[1,2-d][1,4]benzodiazepine derivatives and related 1,4- benzodiazepines as anticonvulsant agents in DBA/2 mice 61
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 60
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 60
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 60
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 60
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 60
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 60
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 60
AMPA Receptor Antagonists as Potential Anticonvulsant Drugs 59
Synthesis and anticonvulsant activity of triazolo[4,5-c][2,3]benzodiazepines 59
Electronic and conformational properties of 2,3-benzodiazepine derivatives 59
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 58
Efficient 3D Database screening for novel HIV-1 IN inhibitors 58
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 58
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 58
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 58
NOVEL ANNELATED 1,4-BENZODIAZEPINES AND 1,5-BENZODIAZEPINES 57
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 57
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 57
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 57
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 57
Antiretroviral strategy using multi-target agents 57
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 57
Successful optimization of human carbonic anhydrase inhibitors as neuroprotective agents 57
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 57
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 56
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 56
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 56
HIV-1 integrase strand-transfer inhibitors: design and synthetic strategies in the process of a lead optimization 56
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 56
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 56
2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4 56
Design e sintesi di nuovi Antagonisti Noncompetitivi del Recettore AMPA 55
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 55
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 55
Synthesis and pharmacological evaluation of 4-aryl-6,7- dimethoxyphthalazines as anticonvulsant agents 55
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 55
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 55
Pyrrolo[1',2':1,2]imidazo[4,5-b]pyridines, pyrrolo[2',1':2,3]imidazo[4,5-c]pyridines and pyrrolo[2,1-f]purines as potential benzodiazepine receptor ligands. 55
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 55
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 54
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 54
Synthesis, structural features and anti-HIV activity of TBZ analogues 54
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 54
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 54
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 54
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 54
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 54
Determinatiopn of a new AMPA receptor antagonist in rat brain by HPLC 53
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 53
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 53
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 53
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 53
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 53
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 53
Totale 6.771
Categoria #
all - tutte 60.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201917 0 0 0 0 0 0 0 0 0 0 0 17
2019/20203.066 631 277 8 261 10 319 407 341 35 314 455 8
2020/20212.634 326 3 432 89 51 310 8 277 5 276 235 622
2021/20221.911 22 339 48 59 108 9 132 76 37 25 367 689
2022/20235.684 471 420 263 419 502 616 118 341 2.258 17 217 42
2023/20241.275 109 219 85 224 120 208 24 64 2 109 34 77
Totale 16.555